Needham analyst Mayank Tandon reiterates PAR Technology (NYSE:PAR) with a Buy and maintains $43 price target.
SVB Leerink Maintains Outperform on Surgery Partners, Raises Price Target to $63
SVB Leerink analyst Whit Mayo maintains Surgery Partners (NASDAQ:SGRY) with a Outperform and raises the price target from $61 to $63.